Starpharma Holdings Limited (ASX:SPL) has launched VivaGel® BV in Central and Eastern European region. VivaGel® BV is now available Over the counter (OTC) in Western and Eastern European countries.
Moreover, further launches are also intended in other Mundipharma territories, including in Asia, as well as regulatory activities continue in multiple regions.
Post announcement share price of SPL climbed by 7.938% to A$1.047 (at AEST 12:08 PM) on 16 June 2020.
Disclaimer
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.
